Phase I study, and dosing regimen selection for a pivotal COVID-19 trial of GST-HG171. Zhang H, Zhou J, Chen H, Mao J, et al. Antimicrob Agents Chemother 2023 Dec 15:e0111523. doi: 10.1128/aac.01115.

Read + Share

Amedeo Smart

Independent Medical Education

Zhang H, Zhou J, Chen H, Mao J, et al. Phase I study, and dosing regimen selection for a pivotal COVID-19 trial of GST-HG171. Antimicrob Agents Chemother 2023 Dec 15:e0111523. doi: 10.1128/aac.01115.
PMID: 38099673